Gossamer Bio, Inc. (GOSS)
10.32
-0.37
(-3.46%)
USD |
NASDAQ |
Oct 30, 16:00
10.20
-0.12
(-1.16%)
After-Hours: 18:47
Gossamer Bio Cash and Short Term Investments (Annual) : 136.93M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 136.93M |
| December 31, 2024 | 294.52M |
| December 31, 2023 | 296.42M |
| December 31, 2022 | 255.68M |
| December 31, 2021 | 325.28M |
| Date | Value |
|---|---|
| December 31, 2020 | 513.19M |
| December 31, 2019 | 401.83M |
| December 31, 2018 | 228.86M |
| December 31, 2017 | 0.315M |
| December 31, 2016 | 0.06M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| United Therapeutics Corp. | 2.920B |
| Arbutus Biopharma Corp. | 91.47M |
| Kura Oncology, Inc. | 667.24M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |